Cbd And Hemp Consumer Products

Bod Australia continues to break sales records

Finfeed Archived May 10, 2021

Bod Australia (ASX: BDA) today announced its highest ever monthly sales for its medicinal cannabis prescription products. BDA attributes its current growth to its Australia wide clinical study to test the efficacy of MediCabilis™ when prescribed for conditions including anxiety, insomnia, and Post Traumatic Stress Disorder (PTSD).